Wearable Tech: A Game-Changer for Monitoring Mild Cognitive Impairment

Medical Innovations: Mild cognitive impairment (MCI) is a condition that affects over 15% of older adults worldwide. Characterized by noticeable lapses in memory and thinking skills, MCI often precedes more severe conditions such as Alzheimer’s disease and dementia. Traditional methods of monitoring MCI rely on periodic clinical tests, which leave significant gaps in data. However, a groundbreaking study led by Dr Yuri Rykov at Neuroglee Therapeutics in Singapore suggests that wearable technology could revolutionize how we monitor cognitive function in patients with MCI. This Medical Innovations news report delves into the study's findings, the potential of wearable technology, and future directions for research.


Wearable Tech: A Game-Changer for Monitoring Mild Cognitive Impairment

Bridging the Data Gap with Wearable Technology
Traditional neuropsychological tests for MCI are conducted during clinic visits, capturing data only intermittently. This method leaves substantial gaps, particularly when patients are not in a clinical setting. Wearable sensors, such as the Fitbit, are already capable of collecting various physiological data points, including heart rate and heart rate variability (HRV). Previous studies have shown a correlation between HRV metrics and cognitive function, specifically executive function and episodic memory. Building on this research, Dr. Rykov’s team explored the potential of wearable sensors to provide continuous monitoring of cognitive function in patients with MCI.
 
The Clinical Trial: Methodology and Implementation
The 10-week clinical trial involved older adults aged 50-70, including 30 individuals diagnosed with amnestic MCI and 10 age-matched cognitively normal individuals. Participants underwent regular therapeutic intervention sessions delivered digitally and wore the Empatica E4 wrist-wearable device during these sessions, as well as during sleep and routine activities. The device recorded physiological data, such as blood volume pulse, electrodermal activity, acceleration, and skin temperature. Cognitive performance was measured at the start and end of the trial using the neuropsychological battery test (NTB), assessing executive function, processing speed, memory, and global cognition.
 
Key Findings: Correlations and Predictive Models
The study yielded several significant findings:

-Strong Correlations: Digital physiological features showed strong correlations with processing speed, executive function, and global cognition composite scores.
 
-HRV Metrics: Measures of HRV, particularly the cardiac sympathetic index (CSI) and high frequency HRV (HRV-HF), correlated significantly with cognitive composites.
 
-Predictive Models: Models combining digital physiological features and demographics demonstrated high predictability for executive function scores.
 
These results underscore the po tential of wearable technology for continuous monitoring of cognitive function in patients with MCI, with HRV measures showing particular promise in predicting cognitive performance.
 
Advantages of Continuous Monitoring
Continuous monitoring through wearable technology offers clinicians a convenient method to gather patient data outside the clinic. This can be especially beneficial after implementing new treatment protocols or during periods of significant health deterioration. For instance, if a patient experiences severe cognitive decline, wearable sensor data could help pinpoint when these changes occurred, providing valuable insights for treatment adjustments.
 
Study Limitations and Future Research Directions
Despite its promising findings, the study had several limitations:
 
-Small Sample Size: The study involved a relatively small number of participants, and non-compliance led to the loss of some data.
 
-Short Study Period: The trial lasted only 10 weeks, potentially missing long-term effects.
 
-Lack of Ethnic Variation: The study sample lacked ethnic diversity, limiting the generalizability of the results.
 
Future research should aim to control for more external factors, include a larger and more diverse sample, and extend the study period to capture long-term effects. A more controlled study design, possibly incorporating a control group that does not receive the intervention, would enhance the validity and generalizability of the findings.
 
Harnessing Machine Learning for Cognitive Monitoring
Machine learning played a crucial role in this study by training models to predict NTB scores using digital physiological features and demographics. The use of machine learning methods allowed the researchers to develop predictive models with impressive accuracy. For instance, the model predicted executive function scores with a correlation of 0.69 and intra-individual changes in executive function scores with a correlation of 0.61. These results highlight the added predictive value of digital physiological features over demographic information alone.
 
Exploring the Heart-Brain Connection
The study’s findings align with the heart-brain axis theory, which posits a two-way circuit between the central and autonomic nervous systems. The significant correlations between HRV measures and cognitive function, particularly executive function, support this theory. Executive function tasks often require optimal heart function for distributing oxygenated blood, consistent with the neurovisceral integration model.
 
Strengths and Innovations of the Study
The study had several strengths:
 
-Longitudinal Design: This allowed the researchers to examine associations between physiological measures and cognitive function over time.
 
-Use of Centered Data: This approach mitigated inter-individual differences, revealing intra-individual changes.
 
-Nocturnal Data Collection: Collecting physiological signals during sleep minimized psychological and behavioral confounders related to wakeful activity.
 
Limitations and Recommendations for Future Research
The main limitation was the small sample size, necessitating verification with an independent sample. Additionally, the study’s short duration and homogeneous sample limit its generalizability. Future research should involve larger, multi-ethnic samples, longer follow-up periods, and include a control group. Researchers should also explore the value of combining physiological measures with other digital phenotyping data, such as speech, language use, and software interaction.
 
Conclusion: A Promising Future for Cognitive Monitoring
In conclusion, the study demonstrates that physiological measures correlate with cognitive function in individuals with MCI. Wearable technology holds significant potential for passive, continuous assessment of cognitive function, allowing for better understanding and more effective treatment of MCI. The findings warrant further research to validate these physiological measures and evaluate their combined value with other digital phenotyping data. With continued advancements, wearable technology could transform the monitoring and treatment of cognitive impairment, improving outcomes for millions of individuals worldwide.
 
The study findings were published in the peer reviewed journal: BMC Medicine.
https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-024-03252-y
 
For the latest Medical Innovations, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/ai-in-medicine-yale-scientist-develop-ai-model-that-can-detect-left-ventricular-systolic-dysfunction-lvsd-from-ecgs-obtained-by-wearable-devices
 
https://www.thailandmedical.news/news/covid-19-innovations-kyocera-develops-wearable-remote-monitoring-device-for-covid-19-patients
 
https://www.thailandmedical.news/news/medical-innovations-new-wearable-vitamin-c-sensor-for-dietary-tracking
 
https://www.thailandmedical.news/news/medical-devices-for-covid-19-northwestern-university-develops-new-sticker-like-device-that-offers-continuous-monitoring-for-covid-19